This News & Views article by Daniel M. Altmann and Rosemary J. Boyton was published in Nature Immunology on 14 August 2026. The piece comments on recent research into immune responses to SARS‑CoV‑2 and frames those findings within the broader concept of immune imprinting and immune memory. The authors are based at Imperial College London and declare no competing interests.
The central message is that effective immunity to an evolving pathogen such as SARS‑CoV‑2 can arise from a balance between two complementary processes: the recall of existing immune memory and the generation of variant‑specific antibodies de novo. The authors summarize how recent research supports this view and emphasize that both broadly reactive imprinted antibodies and newly generated, type‑specific antibodies can contribute to protective responses against viral variants.
Altmann and Boyton draw on recent studies of SARS‑CoV‑2 to illustrate how prior exposure shapes subsequent antibody responses. The commentary references an associated open‑access article in the same issue that examines the relationship between potent type‑specific de novo antibodies and broadly reactive imprinted antibodies in responses to variants. The News & Views situates these SARS‑CoV‑2 observations within a literature that includes prior reviews and primary studies of immune imprinting and viral evolution.
The article discusses immune imprinting as a biological phenomenon in which earlier immune encounters influence the specificity and breadth of later responses. In the context of SARS‑CoV‑2, imprinting can lead to the preferential recall of memory B cell responses that recognize conserved epitopes, producing broadly reactive antibodies. At the same time, exposure to antigenically drifted variants can drive de novo affinity maturation and generation of variant‑specific neutralizing antibodies. The authors emphasize that both recall and de novo processes are important and can act in a complementary fashion to shape overall immunity.
A key implication highlighted is the translational potential of intentionally designing vaccines and immunization strategies that account for immune imprinting. By understanding how prior exposures bias subsequent responses, vaccine approaches might aim to preserve or elicit broadly protective imprinted responses while also enabling robust de novo responses to variant epitopes. The authors present this conceptual framework as directly relevant to strategies for updating or formulating vaccines against evolving pathogens such as SARS‑CoV‑2.
The article includes a figure (Fig. 1) titled “Exploiting understanding of immune imprinting to build a future‑proofed repertoire.” The figure is presented to illustrate how knowledge of imprinting could be used when designing vaccines to generate a balanced repertoire that leverages both remembered broad reactivity and newly induced variant specificity.
Authors: Daniel M. Altmann and Rosemary J. Boyton, affiliated with departments at Imperial College London. The authors declare no competing interests. The piece is a News & Views commentary that summarizes and interprets recent primary research rather than presenting new experimental data in full; detailed datasets, experimental methods and quantitative outcomes are not included in the previewed content. The article cites recent reviews and primary studies relevant to imprinting and SARS‑CoV‑2, and points readers to an associated open‑access research article in the same issue for experimental details.
Notes on scope and source material
This summary is based solely on the provided Nature Immunology preview content. The News & Views highlights conceptual advances and translational implications rather than reporting new trial or mechanistic data in full; readers seeking experimental detail should consult the cited primary research articles referenced by the authors, including the associated open‑access Nature Immunology article in the same issue.